Trichoscopy in Diagnosis of Immunobollous Diseases
NCT03478072 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2018-07-30
Summary
Autoimmune bullous diseases are a variety of skin diseases that are characterized by the presence of bullae or blisters. Most of these diseases are associated with substantial morbidity and mortality. They are classified according to the site of blister formation into intraepidermal as pemphigus valgaris and foliaceus, and subepidermal as bullous pemphigoid and dermatitis herpetiformis. These lesions commonly affect the scalp and manifest as blisters, erosions and crustations.
Trichoscopy (hair and scalp dermoscopy) is a non-invasive technique in which either a handheld dermoscope or a digital videodermoscope can be used to visualize hair and scalp structures. The method has well-established position as an ancillary tool in the diagnosis of many disorders such as, tinea capitis, alopecia areata, androgenetic alopecia, discoid lupus erythematosus, lichen planopilaris, folliculitis decalvans and other hair and scalp diseases. Few studies have reported that immunobullous diseases present characteristic trichoscopic patterns. So, Trichoscopy can be used as a rapid in-office preliminary diagnostic tool in the differential diagnosis of these diseases.
Conditions
- IMMUNOBULLOUS DISEASES
Interventions
- DEVICE
-
trichoscopy
hair and scalp dermoscopy) is a non-invasive technique in which either a handheld dermoscope or a digital videodermoscope can be used to visualize hair and scalp structures
Sponsors & Collaborators
-
tasbeeh salah
lead OTHER
Principal Investigators
-
Nagwa Easa, prof · prof
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-01
- Primary Completion
- 2019-12-01
- Completion
- 2020-06-01
More Related Trials
-
Evaluate the Evolution of Body and Scalp Skin Discomfort in Patients With Hereditary Ichthyosis After Wraps (EnvelopIchtyose)
NCT05979506 ·Status: RECRUITING ·Phase: NA
-
Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
NCT06834035 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
NCT06387654 ·Status: RECRUITING
-
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
NCT02471352 ·Status: RECRUITING
-
Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita
NCT00004359 ·Status: COMPLETED ·Phase: PHASE2
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
Serum IL-21 Levels in Patients With Pemphigus Vulgaris
NCT03177213 ·Status: UNKNOWN
-
Identification of Vulnerability Factors in the Course of Pemphigus Patients
NCT02237313 ·Status: COMPLETED ·Phase: NA
-
Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis
NCT07276425 ·Status: RECRUITING
-
Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT01874769 ·Status: COMPLETED
-
Coagulopathy of Immunodermatologic Diseases
NCT06037187 ·Status: RECRUITING
-
Trichoscopy and Systemic Scleroderma
NCT04804930 ·Status: RECRUITING
-
Coagulation Activation in Patients With Pemphigus
NCT06285435 ·Status: NOT_YET_RECRUITING
-
Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa
NCT04217538 ·Status: COMPLETED
-
Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis
NCT00043706 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
NCT00368784 ·Status: COMPLETED
-
Exploratory Study of Natural Killer Cells in Human Skin
NCT00824889 ·Status: COMPLETED ·Phase: NA
-
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
NCT06087627 ·Status: RECRUITING
-
Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine
NCT00775463 ·Status: COMPLETED ·Phase: PHASE2
-
Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?
NCT03636763 ·Status: UNKNOWN
-
Vitiligo Treatment by Targeting TYK2 Mediated Responses
NCT06327321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients
NCT06167408 ·Status: COMPLETED
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)
NCT03740724 ·Status: TERMINATED ·Phase: PHASE1/PHASE2